Filing Details

Accession Number:
0000950123-20-006771
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-07 17:39:30
Reporting Period:
2020-07-02
Accepted Time:
2020-07-07 17:39:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc. MYOK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413822 Anastasios Gianakakos C/o Myokardia, Inc.
1000 Sierra Point Parkway
Brisbane CA 94005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-02 1,776 $93.55 22,346 No 4 S Direct
Common Stock Disposition 2020-07-02 3,224 $94.22 19,122 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 129,407 Indirect By Reporting Person's Trust 2
Common Stock 300,000 Indirect By Reporting Person's Trust 4
Common Stock 7,000 Indirect By Reporting Person's Trust 5
Common Stock 10,000 Indirect By reporting Person's Trust 6
Common Stock 53,087 Indirect By Trust 1
Common Stock 53,087 Indirect By Trust 2
Common Stock 53,087 Indirect By Trust 3
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 3, 2019.
  2. Represents the weighted average sale price of the shares sold ranging from $92.98 to $93.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
  3. Represents the weighted average price of the shares sold ranging from $94.01 to $94.75 per share.